ARTELO BIOSCIENCES, INC. (ARTL) › Operating Cash FlowARTELO BIOSCIENCES, INC. (ARTL) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2017: -$216.8K2018: -$1.61M2019: -$2.79M2020: -$4.35M2021: -$6.14M2022: -$8.01M2023: -$8.21M2024: -$8.35M2025: -$8.52M-$8.52M2017Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$8.52M-2.0%2024-$8.35M-1.7%2023-$8.21M-2.5%2022-$8.01M-30.4%2021-$6.14M-41.3%2020-$4.35M-55.7%2019-$2.79M-73.5%2018-$1.61M-642.6%2017-$216.8K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share